top of page

TPP Lifesci

Our Approach

TPP’s leadership brings decades of experience in regulatory strategy, marketing research, manufacturing, and commercial execution with a proven track record in 505(b)(2) launches, ASC engagement, and payer strategy. Deeply understands various therapeutic areas such as oncology, anesthesia/ pain management, and CNS. 

  • Extensive industry relationships across ASCs, GPOs, and hospital networks

  • Expertise in formulary adoption, field execution, and market expansion

  • Strategic investment, licensing, and partnerships with life science innovators and global organizations

  • Seamless navigation and execution in the U.S. biopharmaceutical market for sustained success​​

Cooperation Model

Product resumé

TPP Lifesci 505(b)(2) products

TPP has developed two 505(b)(2) drugs in the oncology and pain management area:

  • Successful development, FDA approval, launch and licensing of our 505(b)(2) Focinvez to Amneal.

  • In-licensed Qamzova in 2025 and preparing for commercialization.

  • Expert in branding, J-code and pricing strategy, sales and marketing.

  • Build up of product value from product proposition and product story to launch.

Direct access to all major U.S. distributors:

  • Cardinal Health

  • McKesson

  • Cencora (formerly AmerisourceBergen)

  • Morris & Dickson

qamzova.png

Regulatory and Quality Expertise

Our Team Consists Of:

  • Senior regulatory and quality professionals with decades of experience in sterile manufacturing, aseptic processing, and CMC development across drugs, biologics, and combination products.

  • Directly involved in over 1,000 NDA, sNDA, ANDA, and DMF submissions to the FDA, including numerous approvals for sterile injectable and complex 505(b)(2) products.

  • Proven track record in sterility assurance, contamination remediation, rapid microbiology methods, and regulatory compliance restoration for companies under FDA remediation.

  • Recognized industry expert serving on FDA advisory committees for aseptic processing and rapid methods; author of multiple PDA/DHI technical reports and award-winning publications on environmental monitoring and sterilization validation.

  • Holds CQE and CQM certifications (ASQ) and has led quality system redesigns for global pharma manufacturers to meet FDA and international GMP standards.

Proposed rHSA Distribution Framework

  • Ability to secure special placement and consignment programs for health systems and plasma centers.

  • Provides direct access to the largest hospital, specialty, and plasma-buying networks in the U.S. via:

    • FFF Enterprises

    • Cardinal Specialty

    • McKesson Biologics and Plasma

    • Health Coalition

  • Access via Vizient, the largest GPO, allowing for customized marketing programs to target high-value albumin users.

  • TPP TECH can immediately build a nationwide commercial framework for recombinant human serum albumin (rHSA).

TPP Strategic Distribution & GPO Access

Established relationships with key national accounts:

  • GPOS: Vizient, HPG, Premier

  • Retail: CVS, Walgreens, Kroger, Publix

  • PBM/Partner: ClarusOne, Apexus 340B

Direct access to all major U.S. distributors:

  • Cardinal Health

  • McKesson

  • Cencora (formerly AmerisourceBergen)

  • Morris & Dickson

Brands.png

Opportunity Identification & Research

Precise market research and respective analysis are essential in drug development, providing critical insights into market response, stakeholder feedback, and financial planning. A strong data-driven foundation minimizes risks, optimizes decision-making, and enhances commercial success.

Specialized expertise in designing strategic product pipelines aligned with the U.S. Pharma market's regulatory, commercial, and competitive dynamics. Key Considerations TPP Works Through with Partners:

  • Product Differentiation – Identifying unique, well-documented competitive advantages.

  • Market Viability – Assessing real and actionable unmet needs in the therapeutic area

  • Regulatory & Development Risk – Evaluating feasibility, approval pathways, and clinical hurdles.

  • Commercial Strategy – Defining pricing, reimbursement potential, and market positioning

Timing

What is the opportunity?

Phase 1, Preliminary Product Assessment:

For partners developing new entities or 505(b)(2) (re)formulations, we conduct targeted early-stage market research and analysis with key stakeholders to assess unmet needs, key differentiators, practitioner acceptance, and the overall landscape for commercial viability.

Phase 2, Deep-Dive Product Validation:​

With positive Phase 1 feedback and a defined product narrative and related competitive strategy, we facilitate engagement with payers, distributors, societies, large practices, and other C-Suite colleagues to identify probable reimbursement dynamics, competitive landscape items of note, and potential pricing strategies/scenarios—ensuring a well-planned and defined path to successful commercialization.

Market Intelligence & Strategic Insights

Leveraging in-depth research across U.S. stakeholders, including KOLs, physicians, and payers, to obtain actionable intelligence that reduces risk, enhances decision-making, and optimizes our market entry and commercialization strategies

Stakeholder Feedback

Qualitative U.S. Market Research

​

  • Market Strategy & Planning – Understanding key data, trends, and competitive dynamics.

  • Healthcare Provider Surveys – Designing targeted surveys and interpreting responses.

  • Market Opportunity Analysis – Identifying actionable solutions for product positioning.

Expert-Led Market Research:

We conduct substantive, one-on-one interviews with subject matter experts (SMEs) to provide deep strategic insights on:

Advisory  Discussion Panels/Boards:

A focused multi-disciplinary roundtable of healthcare professionals (HCPs) and industry experts offering real-time perspectives on:

​

  • Idea Validation – Ensuring product-market fit and feasibility.

  • New Product Conceptualization – Refining innovations based on industry needs.

  • Reformulation & Market Entry SWOT Analysis – Evaluating strengths, weaknesses, opportunities, and threats for new or modified products.

Regulatory Support

We assist innovative companies from the earliest stages of FDA engagement,  ensuring a streamlined, step-by-step approach to regulatory compliance. With our expert guidance, companies can confidently navigate U.S. regulatory requirements.

Regulatory Support

Here is what we can do

We partner with innovative companies from the early stages of FDA engagement, ensuring a streamlined, step-by-step approach to regulatory compliance. With our expert guidance, companies can confidently navigate U.S. regulatory requirements. Our expertise ensures a seamless regulatory pathway, allowing our partners to focus on innovation with confidence. 

  • U.S. Agent & Company Registration – We are your US partner to ensure compliance with all US regulations and registration.

  • Document Review & Optimization – We have a strong track record of success with submissions for regulatory approval. 

  • Applications for FDA – We have in-depth experience with NDA#, NDC#, GTIN#, and J-Code registrations. 

  • Branding & Labeling Compliance – We develop creative brand names and strategies, logos, & labels with experience in complete documentation.

  • eCTD Submission – Our experts prepare and manage the complete process for electronic submissions for FDA review.

Strategic Planning & Market Execution

Successful Commercialization Requires the Right Team to Bring a product to market. The right team should be able to deeply understand the product, knowledge, and expertise in its field to ensure a successful launch and long-term lifecycle management.

Commercialization

As a trusted commercialization partner, we provide:

  • Integrity: Our unwavering commitment to integrity means we can be relied upon for honest and ethical business practices. We prioritize interests, maintain transparency, and uphold the highest standards of integrity in every interaction.

  • Communication: We prioritize clear and consistent communication to ensure that our customers and partners are well informed about our products and services in the market, fostering transparency and trust in our relationships.

  • Collaboration: By promoting collaboration, we tap into diverse expertise to tailor solutions that best meet needs. Working closely together allows us to create value, enhance efficiency, and deliver outcomes exceeding expectations in all business facets.

  • Entrepreneurship: We embrace an entrepreneurial mindset and continuously seek innovative ways to add value for our customers. Our proactive approach to problem-solving and adaptability ensure that we stay ahead of the curve, delivering solutions that drive success.

bottom of page